Get all your news in one place.
100’s of premium titles.
One app.
Start reading

Johnson & Johnson to buy Momenta Pharma for $6.5 billion

Johnson & Johnson on Wednesday said that it will pay $6.5 billion in cash to buy Momenta Pharmaceuticals, representing a 70% premium to where the Massachusetts drugmaker closed trading yesterday.

Why it matters: Johnson & Johnson is seeking to expand its capacity in drugs to treat autoimmune diseases, including a muscle-weakening condition known as myasthenia gravis.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.